Penn Mutual Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Penn Mutual Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$681K	Hold	62,802	–	–	3.5%	5
2026 Q1	$698K	Hold	62,802	–	–	3.57%	6
2025 Q4	$1.04M	Hold	62,802	–	–	0.62%	8
2025 Q3	$739K	Hold	62,802	–	–	1.44%	18
2025 Q2	$602K	Hold	62,802	–	–	1.06%	23
2025 Q1	$394K	Hold	62,802	–	–	0.76%	39
2024 Q4	$510K	Hold	62,802	–	–	0.92%	30
2024 Q3	$1.14M	Hold	62,802	–	–	2.25%	9
2024 Q2	$647K	Hold	62,802	–	–	1.38%	11
2024 Q1	$667K	Hold	62,802	–	–	1.42%	13
2023 Q4	$573K	Hold	62,802	–	–	0.44%	50
2023 Q3	$651K	Hold	62,802	–	–	0.61%	45
2023 Q2	$899K	Hold	62,802	–	–	0.81%	42
2023 Q1	$448K	Hold	62,802	–	–	0.43%	46
2022 Q4	$705K	Sell	62,802 -24,138	-28%	-$249K	0.79%	37
2022 Q3	$963K	Hold	86,940	–	–	1.26%	29
2022 Q2	$734K	Hold	86,940	–	–	0.99%	30
2022 Q1	$1.18M	Buy	+86,940	New	+$1.4M	1.37%	18
2021 Q4	–	Sell	-86,940	Closed	-$2.79M	–	68
2021 Q3	$2.79M	Hold	86,940	–	–	4.41%	7
2021 Q2	$2.94M	Hold	86,940	–	–	3.68%	8
2021 Q1	$3.27M	Hold	86,940	–	–	3.69%	10
2020 Q4	$2.89M	Hold	86,940	–	–	2.55%	12
2020 Q3	$3.19M	Hold	86,940	–	–	4.5%	10
2020 Q2	$2.86M	Buy	+86,940	New	+$3.34M	2.92%	13

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Penn Mutual Asset Management's PHAT Position: Q2 2026 in Review

Penn Mutual Asset Management held its Phathom Pharmaceuticals (PHAT) position steady in Q2 2026 at 62,802 shares worth $681K. The position accounts for 3.5% of the portfolio, ranked #5.

Penn Mutual Asset Management first reported a position in PHAT in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.27M in Q1 2021. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

Penn Mutual Asset Management held 62,802 shares of Phathom Pharmaceuticals worth $681K as of Q2 2026.
Penn Mutual Asset Management left its Phathom Pharmaceuticals share count unchanged in Q2 2026.
Phathom Pharmaceuticals made up 3.5% of Penn Mutual Asset Management's portfolio in Q2 2026, its #5 holding.
Penn Mutual Asset Management first reported a position in Phathom Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
Penn Mutual Asset Management's Phathom Pharmaceuticals position peaked at $3.27M in Q1 2021.
161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Penn Mutual Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.